Showing results (1-10 of 361) with videos related to
Sort By:
Pageof 37
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Viral vector-based therapeutic cancer vaccinesCecilia Larocca, Jeffrey SchlomJournal of the National Cancer Institute|March 8, 2012
Therapeutic cancer vaccines: current status and moving forwardJeffrey SchlomExpert Review of Vaccines|October 9, 2013
Recombinant cancer vaccines and new vaccine targets. Interview by Jenaid ReesJeffrey SchlomHematology/Oncology Clinics of North America|December 1, 2018
Mycosis Fungoides and Sézary Syndrome: An UpdateCecilia Larocca, Thomas KupperExperimental Biology and Medicine (Maywood, N.J.)|April 14, 2011
Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunityCaroline Jochems, Jeffrey SchlomCancer Immunology, Immunotherapy : CII|August 12, 2008
Antigen-presenting cells containing multiple costimulatory molecules promote activation and expansion of human antigen-specific memory CD8+ T cellsSixun Yang, Jeffrey SchlomJournal of Biomedicine & Biotechnology|March 20, 2010
Vaccines against human carcinomas: strategies to improve antitumor immune responsesClaudia Palena, Jeffrey SchlomThe Journal of Infectious Diseases|July 12, 2020
The Importance of Cellular Immunity in the Development of Vaccines and Therapeutics for COVID-19Jeffrey Schlom, Renee N DonahueOncoimmunology|August 2, 2014
Potential utility of the pan-Bcl-2 inhibitor GX15-070 (obatoclax) in cancer immunotherapyPeter S Kim, Jeffrey SchlomPageof 37